Kazia Therapeutics is a pharmaceutical preparations company trading on NASDAQ, led by CEO John Edwin Friend.
Upcoming earnings announcement for Kazia Therapeutics
Past 5 earnings reports for Kazia Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | FY 2024 | -$0.07 | — | $15.6M | — | — |
| Mar 27, 2024 | H1 2024 | -$0.02 | — | $4.2K | — | — |
| Sep 5, 2023 | FY 2023 | -$0.08 | — | $15.6K | — | — |
| Mar 7, 2023 | H1 2023 | -$0.06 | — | $93.2K | — | — |
| Oct 17, 2022 | FY 2022 | $0.14 | — | - | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.